(19)
(11) EP 0 861 322 A1

(12)

(43) Date of publication:
02.09.1998 Bulletin 1998/36

(21) Application number: 95937415.0

(22) Date of filing: 06.10.1995
(51) International Patent Classification (IPC): 
C12N 15/ 09( . )
A61K 38/ 00( . )
A61P 31/ 16( . )
C12N 1/ 21( . )
C12Q 1/ 02( . )
C12Q 1/ 68( . )
C12R 1/ 19( . )
A61K 31/ 00( . )
A61P 31/ 00( . )
C07K 14/ 47( . )
C12N 9/ 04( . )
C12Q 1/ 18( . )
C12Q 1/ 70( . )
(86) International application number:
PCT/US1995/013044
(87) International publication number:
WO 1997/012967 (10.04.1997 Gazette 1997/16)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

(71) Applicant: THE MOUNT SINAI MEDICAL CENTER
New York, NY 10029 (US)

(72) Inventors:
  • PALESE, Peter
    Leonia, NJ 07605 (US)
  • O'NEILL, Robert
    New York, NY 10032 (US)

(74) Representative: Horner, Martin Grenville, et al 
Cruikshank & Fairweather 19 Royal Exchange Square
Glasgow G1 3AE Scotland
Glasgow G1 3AE Scotland (GB)

   


(54) ANTIVIRAL COMPOUNDS THAT INHIBIT INTERACTION OF HOST CELL PROTEINS AND VIRAL PROTEINS REQUIRED FOR REPLICATION